Novapep
1 known investors
Novapep develops therapeutic peptides based on APC agonist structures to treat severe community-acquired pneumonia, focusing on anti-inflammatory and cytoprotective mechanisms.
BiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Novapep do?
- Novapep develops therapeutic peptides based on APC agonist structures to treat severe community-acquired pneumonia, focusing on anti-inflammatory and cytoprotective mechanisms.
- Who are Novapep's investors?
- Novapep's investors include Sydney Angels.